Nexstim Plc Business and Clinical Update Q3 2022
yahoo.com
finance
2022-10-20 06:00:00

Nexstim Oyj

Press release, Helsinki, 20 October 2022 at 9 AM (EEST)



Nexstim Plc Business and Clinical Update Q3 2022

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ('Nexstim' or 'Company') announces the key highlights of the Company's business and clinical operations during Q3 2022.

CEO Mikko Karvinen's Business and Clinical Update

After the first positive operating result in the history of the Company in H1 2022, our business has continued to show positive progress during the third quarter of 2022. In line with our main strategic goal, we continue profitable net sales growth, leading to our first operational profit-making financial year while also minimizing future equity needs.
